Newsletter | April 16, 2025

04.16.25 -- Applying AI To Identify Synergistic Drug Combinations For Cancer Treatment

SPONSOR

The 5th mRNA-Based Therapeutics Summit returns to Boston as the world's largest, end-to-end mRNA conference, gathering 350+ global stakeholders, sharing exclusive scientific and strategic insights from the biggest and newest players in the mRNA field. Register now

FOCUS ON TRANSLATIONAL RESEARCH

Applying AI To Identify Synergistic Drug Combinations For Cancer Treatment

By combining drugs/therapies with different mechanisms of action, different pathways in cancer cells can be targeted, potentially leading to improved patient outcomes. Using AI is hastening this research.

The Future Promise Of Advanced Therapies In Ophthalmology

Six years after the first approved gene therapy in ophthalmology, the field is experiencing a surge of activity. Delve into the exciting potential of advanced therapies for eye diseases.

Exploring RNA Structure And Ligand Interactions With MMS

Learn about using micropholytic modulation spectroscopy (MMS) to probe RNA base pair and ligand interactions in solution. This research explores the effects of lipid adducts on RNA structure.

Multiplexing In Real-Time PCR Experiments

Discover the capabilities of qPCR multiplexing. Delve into the principles of qPCR multiplexing, highlighting its efficiency in detecting and quantifying multiple genetic targets within a single reaction.

Cancer Biomarkers Guide

Identify the right cancer biomarkers for your research, and find highly recommended antibodies for IHC applications.

Flow Cytometry Workflow Journey

You have designed your flow cytometry panel for cell manufacturing and patient monitoring. Now what? Use this journey map to help ensure optimal resolution of your populations of interest.

T-Cell Manufacturing: When Is The Right Time To Automate?

Automation enhances efficiency and minimizes contamination risks and labor costs. Despite the initial investment in automation equipment, the long-term savings can be significant.

TRANSLATIONAL RESEARCH SOLUTIONS

On-Target And Off-Target Assessment Assays - MaxCyte, Inc.

Connect With Cell & Gene: